Related Blog Posts
HRT- Increase or Reduce the Risk of Heart Disease
18 hours ago ago from Cancer 101
Our culture has gone from ignoring the menopause to medicalizing it. Western medicines now take this normal transition as Oestrogen-deficiency disease. Many women are enthusiastic receiver of hormone replacement therapy and yet many live perfectly without it. The question here: is HRT (Hormone Replacement Therapy) the likely solution to healthy ageing in women? If hormone replacement therapy is a good ad vocation, need I remind us of Japanese ...
Related contentCombined Lapatinib And Nab-Paclitaxel (Abraxane) Shows Good Activity In HER2+ Breast Cancer
10 hours ago ago from Medical Dude
SAN ANTONIO Investigators are reporting favorable results in a pilot neoadjuvant trial that tested a combination of lapatinib and nab-paclitaxel (AbraxaneR) for the treatment of HER2+ breast cancer. The findings were announced at the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) by Virginia Kaklamani, MD, with Northwestern University in Chicago, Illinois. Lapatinib, a dual kinase [...] Related posts: Lives Of Patients With ...
Related contentThe New Mammogram Guidelines - What You Need to Know
21 hours ago ago from The Blog that Ate Manhattan
Unless you've been living on another planet, you know by now that in mid-November, the US Preventive Services Task Force released new recommendations on screening mammography, in which they recommended against routine mammogram screening in women under age 50, and recommended that mammograms be every two years in women ages 50-74. Here's how the guidelines read - The USPSTF recommends against routine screening mammography in women ...
Related contentFDA Says 'Unlikely' That Vytorin, Zetia Increase Cancer Risk
16 hours ago ago from Dallas Fort Worth Injury Lawyer Blog
The U.S. Food and Drug Administration said it's "unlikely" Merck & Co.'s cholesterol drugs Vytorin and Zetia increase the risk of cancer or cancer-related death. Still, the FDA said it can't "definitively" rule out that the drugs may be associated with increased cancer risk. "Based on the currently available information, FDA believes it is unlikely that Vytorin or Zetia increase the risk of cancer or cancer-related death, but at ...
Related contentNew Study Shows Link Between HRT And Breast Cancer
20 hours ago ago from BV Treatment
The results of the second part of the Women's Health Initiative (WIH), a federal study on hormone replacement therapy (HRT) and breast cancer, were released December 13, 2008 at the San Antonio Breast Cancer Symposium. The new findings show that a much higher risk of breast cancer is one of several hormone replacement therapy side effects. HRT Side Effects The results of this new study indicate that the risks of HRT far outweigh the ...
Related contentRelated News
Nothing to see... move along.
